1. Home
  2. GORO vs SLN Comparison

GORO vs SLN Comparison

Compare GORO & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$1.43

Market Cap

212.0M

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$7.11

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
SLN
Founded
1998
1994
Country
United States
United Kingdom
Employees
N/A
116
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.0M
236.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GORO
SLN
Price
$1.43
$7.11
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$1.63
$42.60
AVG Volume (30 Days)
1.8M
425.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
91.80
N/A
EPS
N/A
N/A
Revenue
$99,759,000.00
N/A
Revenue This Year
$25.99
N/A
Revenue Next Year
$5.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
51.78
N/A
52 Week Low
$0.43
$3.54
52 Week High
$1.87
$8.40

Technical Indicators

Market Signals
Indicator
GORO
SLN
Relative Strength Index (RSI) 47.33 53.27
Support Level $1.27 $5.88
Resistance Level $1.49 $7.21
Average True Range (ATR) 0.10 0.54
MACD -0.02 -0.05
Stochastic Oscillator 19.74 49.42

Price Performance

Historical Comparison
GORO
SLN

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: